近日,国际食品安全当局网络(INFOSAN)通报,建议暂停使用所有标识为Oxy Elite Pro和VERSA-1的美国膳食补充剂。INFOSAN通报,已确定65例(美国62例、爱尔兰1例、新西兰2例)不明原因的急性非病毒性肝炎患者曾服用过减肥或增强肌肉的膳食补充剂(美国USP Labs公司生产,标识为Oxy Elite Pro),该产品未经美国食品药品监管局(FDA)批准使用了新成分Aegeline。目前,该产品是否与肝病有直接因果关系 Recently, the International Food Safety Authorities Network (INFOSAN) informed that it is proposed to suspend all US dietary supplements identified as Oxy Elite Pro and VERSA-1. INFOSAN reported that 65 patients (62 in the United States, 1 in Ireland and 2 in New Zealand) had been identified as dietary supplements for weight loss or muscle enhancement (USP Labs, identified as Oxy Elite Pro), the product has not been approved by the U.S. Food and Drug Administration (FDA) for the new ingredient Aegeline. Currently, the product has a direct causal relationship with liver disease